247 related articles for article (PubMed ID: 33420367)
1. Integrin alpha5 in human breast cancer is a mediator of bone metastasis and a therapeutic target for the treatment of osteolytic lesions.
Pantano F; Croset M; Driouch K; Bednarz-Knoll N; Iuliani M; Ribelli G; Bonnelye E; Wikman H; Geraci S; Bonin F; Simonetti S; Vincenzi B; Hong SS; Sousa S; Pantel K; Tonini G; Santini D; Clézardin P
Oncogene; 2021 Feb; 40(7):1284-1299. PubMed ID: 33420367
[TBL] [Abstract][Full Text] [Related]
2. RUNX2 promotes breast cancer bone metastasis by increasing integrin α5-mediated colonization.
Li XQ; Lu JT; Tan CC; Wang QS; Feng YM
Cancer Lett; 2016 Sep; 380(1):78-86. PubMed ID: 27317874
[TBL] [Abstract][Full Text] [Related]
3. Steroid receptor coactivator-1 upregulates integrin α₅ expression to promote breast cancer cell adhesion and migration.
Qin L; Chen X; Wu Y; Feng Z; He T; Wang L; Liao L; Xu J
Cancer Res; 2011 Mar; 71(5):1742-51. PubMed ID: 21343398
[TBL] [Abstract][Full Text] [Related]
4. Pathogenic role of connective tissue growth factor (CTGF/CCN2) in osteolytic metastasis of breast cancer.
Shimo T; Kubota S; Yoshioka N; Ibaragi S; Isowa S; Eguchi T; Sasaki A; Takigawa M
J Bone Miner Res; 2006 Jul; 21(7):1045-59. PubMed ID: 16813525
[TBL] [Abstract][Full Text] [Related]
5. miRNA-30 Family Members Inhibit Breast Cancer Invasion, Osteomimicry, and Bone Destruction by Directly Targeting Multiple Bone Metastasis-Associated Genes.
Croset M; Pantano F; Kan CWS; Bonnelye E; Descotes F; Alix-Panabières C; Lecellier CH; Bachelier R; Allioli N; Hong SS; Bartkowiak K; Pantel K; Clézardin P
Cancer Res; 2018 Sep; 78(18):5259-5273. PubMed ID: 30042152
[TBL] [Abstract][Full Text] [Related]
6. [Integrin α5 silencing inhibits proliferation, invasion and metastasis of human liver cancer Bel-7404 cells
Guo Y; Xu G; Shan M; Yang S
Nan Fang Yi Ke Da Xue Xue Bao; 2020 Jun; 40(6):893-898. PubMed ID: 32895194
[TBL] [Abstract][Full Text] [Related]
7. Regulatory roles of miRNAs 16, 133a, and 223 on osteoclastic bone destruction caused by breast cancer metastasis.
Kitayama K; Kawamoto T; Kawakami Y; Hara H; Takemori T; Fujiwara S; Yahiro S; Miyamoto T; Mifune Y; Hoshino Y; Kakutani K; Matsumoto T; Matsushita T; Niikura T; Kuroda R; Akisue T
Int J Oncol; 2021 Nov; 59(5):. PubMed ID: 34713296
[TBL] [Abstract][Full Text] [Related]
8. Mutant p53-ENTPD5 control of the calnexin/calreticulin cycle: a druggable target for inhibiting integrin-α5-driven metastasis.
Pavlakis E; Neumann M; Merle N; Wieboldt R; Wanzel M; Ponath V; Pogge von Strandmann E; Elmshäuser S; Stiewe T
J Exp Clin Cancer Res; 2023 Aug; 42(1):203. PubMed ID: 37563605
[TBL] [Abstract][Full Text] [Related]
9. Biphasic α2β1 Integrin Expression in Breast Cancer Metastasis to Bone.
Moritz MNO; Merkel AR; Feldman EG; Selistre-de-Araujo HS; Rhoades Sterling JA
Int J Mol Sci; 2021 Jun; 22(13):. PubMed ID: 34199096
[TBL] [Abstract][Full Text] [Related]
10. Anti-IL-20 monoclonal antibody suppresses breast cancer progression and bone osteolysis in murine models.
Hsu YH; Hsing CH; Li CF; Chan CH; Chang MC; Yan JJ; Chang MS
J Immunol; 2012 Feb; 188(4):1981-91. PubMed ID: 22238453
[TBL] [Abstract][Full Text] [Related]
11. Alcohol promotes breast cancer cell invasion by regulating the Nm23-ITGA5 pathway.
Wong AW; Paulson QX; Hong J; Stubbins RE; Poh K; Schrader E; Nunez NP
J Exp Clin Cancer Res; 2011 Aug; 30(1):75. PubMed ID: 21838876
[TBL] [Abstract][Full Text] [Related]
12. ITGBL1 Is a Runx2 Transcriptional Target and Promotes Breast Cancer Bone Metastasis by Activating the TGFβ Signaling Pathway.
Li XQ; Du X; Li DM; Kong PZ; Sun Y; Liu PF; Wang QS; Feng YM
Cancer Res; 2015 Aug; 75(16):3302-13. PubMed ID: 26060017
[TBL] [Abstract][Full Text] [Related]
13. Functional elucidation and methylation-mediated downregulation of ITGA5 gene in breast cancer cell line MDA-MB-468.
Fang Z; Yao W; Xiong Y; Zhang J; Liu L; Li J; Zhang C; Wan J
J Cell Biochem; 2010 Aug; 110(5):1130-41. PubMed ID: 20564209
[TBL] [Abstract][Full Text] [Related]
14. microRNA-124 inhibits bone metastasis of breast cancer by repressing Interleukin-11.
Cai WL; Huang WD; Li B; Chen TR; Li ZX; Zhao CL; Li HY; Wu YM; Yan WJ; Xiao JR
Mol Cancer; 2018 Jan; 17(1):9. PubMed ID: 29343249
[TBL] [Abstract][Full Text] [Related]
15. ABL kinases promote breast cancer osteolytic metastasis by modulating tumor-bone interactions through TAZ and STAT5 signaling.
Wang J; Rouse C; Jasper JS; Pendergast AM
Sci Signal; 2016 Feb; 9(413):ra12. PubMed ID: 26838548
[TBL] [Abstract][Full Text] [Related]
16. Autocrine inhibition of the c-fms proto-oncogene reduces breast cancer bone metastasis assessed with in vivo dual-modality imaging.
Jeffery JJ; Lux K; Vogel JS; Herrera WD; Greco S; Woo HH; AbuShahin N; Pagel MD; Chambers SK
Exp Biol Med (Maywood); 2014 Apr; 239(4):404-13. PubMed ID: 24599884
[TBL] [Abstract][Full Text] [Related]
17. ABCC5 supports osteoclast formation and promotes breast cancer metastasis to bone.
Mourskaia AA; Amir E; Dong Z; Tiedemann K; Cory S; Omeroglu A; Bertos N; Ouellet V; Clemons M; Scheffer GL; Park M; Hallett M; Komarova SV; Siegel PM
Breast Cancer Res; 2012 Nov; 14(6):R149. PubMed ID: 23174366
[TBL] [Abstract][Full Text] [Related]
18. Simvastatin prevents skeletal metastasis of breast cancer by an antagonistic interplay between p53 and CD44.
Mandal CC; Ghosh-Choudhury N; Yoneda T; Choudhury GG; Ghosh-Choudhury N
J Biol Chem; 2011 Apr; 286(13):11314-27. PubMed ID: 21199873
[TBL] [Abstract][Full Text] [Related]
19. Increased regucalcin gene expression extends survival in breast cancer patients: Overexpression of regucalcin suppresses the proliferation and metastatic bone activity in MDA-MB-231 human breast cancer cells in vitro.
Yamaguchi M; Osuka S; Weitzmann MN; Shoji M; Murata T
Int J Oncol; 2016 Aug; 49(2):812-22. PubMed ID: 27221776
[TBL] [Abstract][Full Text] [Related]
20. Preclinical evaluation of zoledronate using an in vitro mimetic cellular model for breast cancer metastatic bone disease.
Dedes PG; Kanakis I; Gialeli Ch; Theocharis AD; Tsegenidis T; Kletsas D; Tzanakakis GN; Karamanos NK
Biochim Biophys Acta; 2013 Jun; 1830(6):3625-34. PubMed ID: 23395844
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
